Publication | Closed Access

Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists

Molecular PharmacologyHealth Sciencesμ-Opioid AgonistsPain MedicineDiabetesPharmacologyPostoperative Pain ManagementMolecular PainNeuropharmacologyStreptozotocin-induced DiabetesExperimental PharmacologyPain ManagementPharmacotherapyMedicineκ-Opioid AgonistsOpioid Use DisorderAnesthesiologyPain Research